Dr Michael D Levy is Senior Vice President of Global Pharmacovigilance & Issue Management for Bayer Pharmaceuticals and Bayer Consumer Health since 2014.
Prior to this, he was Head of Global Medical Affairs and Medical Director for Europe/Canada for Bayer Pharmaceuticals since 2010.
Before joining Bayer, Dr Levy was CEO and Founder of Cerulean Bioscience, a privately-held biotechnology company in San Francisco, CA. Previously he was Executive VP of R&D at Nuvelo Inc., a publicly-traded biotech company in San Carlos, CA from 2004 to 2008.
Levy came to Nuvelo from Tularik Inc., a publicly-traded biotechnology company in South San Francisco, CA (acquired by Amgen Inc. in 2004) where he served as Vice President of Development and Chief Medical Officer from 2000 to 2004.
Prior to joining Tularik, Dr Levy spent 12 years at GlaxoSmithKline Inc. in Canada, where he held several positions including his final role as Senior Vice President of R&D and Chief Medical Officer.
Dr Levy earned his BA, MA and medical degrees at Cambridge University, UK He undertook his surgical residency at the Mayo Clinic and received the distinction of being elected, a Fellow of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians.